| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/11/2001 | CN1291199A Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 04/11/2001 | CN1290749A Charcot-leyden crystal IB and its coding sequence and producing method and use |
| 04/11/2001 | CN1290748A New human protein and its coding sequence, and producing method and use |
| 04/11/2001 | CN1290747A New human metal thioalbumen and its coding sequence |
| 04/10/2001 | US6215044 Nucleotide and amino acid sequence; for transgenic plants with altered phenotypes especially during ripening |
| 04/10/2001 | US6214985 Amino acid and nucleotide sequences; diagnosis, prevention, and treatment of autoimmune disorders; antidiabetic agents |
| 04/10/2001 | US6214984 Nucleic acid coding for a linear heavy chain fragment including repeating variable and constant domains; recombinant production |
| 04/10/2001 | US6214981 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 04/10/2001 | US6214974 Internalizable cell binding component having biotin binding element conjugated to biotinylated nucleic acids or cytotoxic moieties such as gelonin, ricin, saporin, abrin, diptheria toxin and the like; gene therapy; drug delivery of toxins |
| 04/10/2001 | US6214973 Antibody light chain having variable region of defined amino acid sequence and human constant region; antitumor agents; anticarcinogenic agents; diagnosis |
| 04/10/2001 | US6214972 Human receptor of defined amino acid sequence; for recombinant preparation of membranes for screening agonists and antagonists; treatment of sleep disorders, allergic rhinitis, glaucoma, congestive heart failure; antiinflammatory agents |
| 04/10/2001 | US6214971 Compounds and methods for the diagnosis and treatment of Babesia microti infection |
| 04/10/2001 | US6214970 Hepatitis E virus antigens and uses therefor |
| 04/10/2001 | US6214614 Cell cycle regulated repressor and DNA element |
| 04/10/2001 | US6214613 Has restriction sites to insert sequences which code for variable domains of antibodies in between sequences coding for other domains of antibodies; expresses polypeptides in membrane-bound form on surface of eukaryotic cells |
| 04/10/2001 | US6214606 Non-chromosomal dna which encodes the protein of defined amino acid sequence; for folding newly synthesized proteins into their biologically active conformation |
| 04/10/2001 | US6214600 Polypeptide of defined amino acid sequence; treatment of alzheimer's disease, stroke, musculoskeletal disease, heart disease, kidney disease; anticarcinogenic/antiinflammatory agents; antiarthritic agents; diagnosis |
| 04/10/2001 | US6214595 Enzymatic polypeptide for utilization in screening bactericides; wound healing agents; for prevent of bacterial wound infections |
| 04/10/2001 | US6214585 Polypeptide hydrozylates for use in food processing; mixing lactobacillus with hydrolyzed polypeptide, heat and recover sweetened hydrozylate |
| 04/10/2001 | US6214584 Nucleotide sequence which encodes polypeptide associated with immunocompetence; for use in the treatment and prevent of tumors, viral diseases, bacterial infections and autoimmune diseases |
| 04/10/2001 | US6214580 Nucleotide sequences coding binding protein associated with apoptosis; for detecting modulators of apoptosis; for treating cancers, sepsis, cachexia, autoimmune and viral diseases, inflammation, nervous system and liver disorders |
| 04/10/2001 | US6214568 Monoclonal antibodies of isotype IgG which bind specifically to glutamate decarboxylase, and uses thereof |
| 04/10/2001 | US6214562 Transcriptionally regualted G protein-coupled receptor |
| 04/10/2001 | US6214547 For secreting polypeptides in yeast |
| 04/10/2001 | US6214543 DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 04/10/2001 | US6214355 DbpA compositions |
| 04/10/2001 | US6214354 Immunizing a person older than fifty who has had varicella or who has had a live varicella vaccine with immunologically effective amount of attenuated varicella zoster virus oka strain, where amount is at least 1,000 plaque forming units |
| 04/10/2001 | US6214348 Administering to the mammal a polypeptide comprising seq id no:2 in an amount sufficient to induce an immunological response to produce antibodies to seq id no:2 |
| 04/10/2001 | US6214346 Bactericides |
| 04/10/2001 | CA2217729C Substance fa-70d, process for producing the same, and uses thereof |
| 04/10/2001 | CA2163151C Humanized and chimeric monoclonal antibodies that recognized epidermal growth factor receptor (egf-r). use diagnostic and therapeutic |
| 04/10/2001 | CA2130436C Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 04/10/2001 | CA2081150C Use of antibody-containing preparations for immunosuppression |
| 04/10/2001 | CA2076901C Kainate-binding, human cns receptors of the eaa2 family |
| 04/10/2001 | CA2074089C Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor |
| 04/10/2001 | CA2020598C Inducible expression vectors |
| 04/10/2001 | CA2015769C Production of biologically active polypeptides through treatment with an exogenous peptide sequence |
| 04/10/2001 | CA1341212C Osteoinductive factors |
| 04/05/2001 | WO2001023602A1 Method for determining and modifying protein/peptide solubility |
| 04/05/2001 | WO2001023598A1 41 human secreted proteins |
| 04/05/2001 | WO2001023597A2 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/05/2001 | WO2001023592A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 04/05/2001 | WO2001023581A1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca |
| 04/05/2001 | WO2001023573A1 Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody |
| 04/05/2001 | WO2001023572A2 Polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | WO2001023571A1 Methods and compositions relating to sodium channel beta1a subunits |
| 04/05/2001 | WO2001023570A2 Methods and compositions relating to sodium channel beta-1a subunits |
| 04/05/2001 | WO2001023565A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | WO2001023557A1 Novel polypeptides and genes encoding the same |
| 04/05/2001 | WO2001023554A1 The prv-1 gene and use thereof |
| 04/05/2001 | WO2001023552A1 Human paralogue of a head trauma induced cytoplasmatic calcium binding protein |
| 04/05/2001 | WO2001023547A1 26 human secreted proteins |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023543A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
| 04/05/2001 | WO2001023540A2 P-glycoproteins and uses thereof |
| 04/05/2001 | WO2001023527A1 Medium for the protein-free and serum-free cultivation of cells |
| 04/05/2001 | WO2001023432A1 Human type complementarity determining region transplantation antibody against ganglioside gd3 and derivatives of antibody against ganglioside gd3 |
| 04/05/2001 | WO2001023431A1 Derivatives of antibody against ganglioside gm2 |
| 04/05/2001 | WO2001023427A1 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/05/2001 | WO2001023425A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/05/2001 | WO2001023416A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 04/05/2001 | WO2001023414A2 Immunologically significant herpes simplex virus antigens |
| 04/05/2001 | WO2001023409A2 38 human secreted proteins |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001022916A2 Novel hev antigenic peptide and methods |
| 04/05/2001 | WO2001022864A2 Sequences characteristic of bladder cancer |
| 04/05/2001 | WO2001006015A8 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 04/05/2001 | WO2000078787A8 ISOLATED GENES FROM VIRULENT GROUP B $i(STREPTOCOCCUS AGALACTIAE) |
| 04/05/2001 | WO2000073450A3 Cytoskeleton-associated proteins |
| 04/05/2001 | WO2000073334A3 Human sorting nexins |
| 04/05/2001 | WO2000071573A3 Immunogenic peptides derived from mage and the use thereof |
| 04/05/2001 | WO2000066143A8 Secreted proteins of mycobacterium tuberculosis and their use as vaccines and diagnostic reagents |
| 04/05/2001 | WO2000065027A3 Human gil-19/ae289 proteins and polynucleotides encoding same |
| 04/05/2001 | WO2000056891A3 Human transmembrane proteins |
| 04/05/2001 | WO2000055343A3 Retrovirus producting cells utilizing a high multiplicity of transduction |
| 04/05/2001 | WO2000031257A9 Novel serine protease bssp6 |
| 04/05/2001 | WO2000020450A9 Calcium channel alpha-2/delta gene |
| 04/05/2001 | DE19947456A1 New synthetic derivatives of the C-peptide of proinsulin, useful in the preparation of human insulin or insulin analogs in high yield |
| 04/05/2001 | DE19947010A1 Das Gen PRV-1 und dessen Verwendung The PRV-1 gene and its use |
| 04/05/2001 | DE19943177A1 Verfahren zur Herstellung von aktiven Serienproteasen und inaktiven Varianten A process for the production of active and inactive variants series proteases |
| 04/05/2001 | CA2387702A1 The prv-1 gene and use thereof |
| 04/05/2001 | CA2386346A1 Novel polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | CA2386197A1 Complementarity determining region-grafted antibody against ganglioside gd3 and derivative of antibody against ganglioside gd3 |
| 04/05/2001 | CA2386077A1 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 04/05/2001 | CA2386029A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | CA2386013A1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca |
| 04/05/2001 | CA2385893A1 Sequences characteristic of bladder cancer |
| 04/05/2001 | CA2385884A1 26 human secreted proteins |
| 04/05/2001 | CA2385743A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/05/2001 | CA2385633A1 Paralogue of a head trauma induced cytoplasmatic calcium binding protein |
| 04/05/2001 | CA2385609A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
| 04/05/2001 | CA2385299A1 Medium for the protein-free and serum-free cultivation of cells |
| 04/05/2001 | CA2385169A1 43 human secreted proteins |
| 04/05/2001 | CA2384981A1 P-glycoproteins and uses thereof |
| 04/05/2001 | CA2384662A1 41 human secreted proteins |
| 04/05/2001 | CA2384659A1 37 human secreted proteins |
| 04/05/2001 | CA2384584A1 38 human secreted proteins |
| 04/05/2001 | CA2384382A1 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/05/2001 | CA2381771A1 Methods and compositions relating to sodium channel beta1a subunits |
| 04/05/2001 | CA2379623A1 Immunologically significant herpes simplex virus antigens |